In the molecular staging of breast cancer, breast cancer is classified into Luminal A, Luminal B, HER2 overexpressing, and basal-like types according to the estrogen receptor, progesterone receptor, and HER2 expression levels, and different molecular staging has a different prognosis and corresponding therapeutic means [6]. This evidence concerns the gene ERBB2 and breast cancer.